Table 2.
Side-Effect | |||
---|---|---|---|
0 | ≥1 | P Value | |
(A) | |||
CYP2D6 *10 | |||
Carrier | 47 (77%) | 14 (23%) | .009 |
Noncarrier | 9 (45%) | 11 (55%) | |
(B) | |||
Genotype | |||
CYP2D6*10 noncarrier & CYP3A4*1G carrier | 2 (25.0%) | 6 (75.0%) | .013 |
Others | 45 (72.6%) | 17 (27.4%) |
a(A) Association between CYP2D6 *10 and adverse side effect in patients prescribed with donepezil or galantamine. (B) Association between CYP2D6 *10 and CYP*3A4 and the occurrence of side effect in patients prescribed with donepezil or galantamine.